HSPA5 and gastric cancer: GRP78 expression is negatively correlated with the growth inhibition rate of DDP (cisplatin) resistant gastric cancer cells, and functional analysis showed that enhanced miR-379-5p expression inhibits the proliferation of DDP resistant gastric cancer cells 73.